Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Mark Flasar"'
Autor:
Martha Skup, Song Wang, Melissa Lingohr-Smith, Jay Lin, Raymond K. Cross, Seema Patil, Jingdong Chao, Mark Flasar
Publikováno v:
Digestive Diseases and Sciences. 64:60-67
Radiation exposure from diagnostic imaging may increase cancer risk of Crohn’s disease (CD) patients, who are already at increased risk of certain cancers. To compare imaging radiation exposure and associated costs in CD patients during the year pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c1fdbfeccbd5503671da45eff50645
https://doi.org/10.1007/s10620-018-5322-y
https://doi.org/10.1007/s10620-018-5322-y
Autor:
Erik C. von Rosenvinge, Kamini Shah, Bryan F. Curtin, Mark Flasar, Daniel Hwang, Christopher Chu
Publikováno v:
World Journal of Clinical Oncology
AIM To evaluate factors associated with Clostridium difficile infection (CDI) and outcomes of CDI in the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) population. METHODS After IRB approval, all MDS/AML patients hospitalized at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87165a1055b2793c8f09b9200f1e5da
http://europepmc.org/articles/PMC5638715
http://europepmc.org/articles/PMC5638715
Autor:
Xinyuan Zhang, Maureen A. Kane, Thomas C. Dowling, Stephen W. Hoag, C. Avon, Soundarya Vaithianathan, Mark Flasar, Tricia Y. Ting, James E. Polli, Changxing Shao, Sam H. Haidar, Wenlei Jiang
Publikováno v:
Journal of Pharmaceutical Sciences. 105:996-1005
The objective was to assess the impact of larger than conventional amounts of 14 commonly used excipients on Biopharmaceutics Classification System (BCS) class 3 drug absorption in humans. Cimetidine and acyclovir were used as model class 3 drugs acr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::640dc51fbb354bb692be0711c36bde44
https://doi.org/10.1002/jps.24643
https://doi.org/10.1002/jps.24643
Publikováno v:
Inflammatory Bowel Diseases
Article first published online 29 September 2015. Supplemental Digital Content is Available in the Text.
Biologic therapy with anti–tumor necrosis factor (TNF)-α antibody medications has become part of the standard of care for medical therapy
Biologic therapy with anti–tumor necrosis factor (TNF)-α antibody medications has become part of the standard of care for medical therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a3d953db96c3f083e3104e1fc8753d
http://europepmc.org/articles/PMC4623843
http://europepmc.org/articles/PMC4623843
Autor:
James E. Polli, Thomas C. Dowling, C. Avon, Soundarya Vaithianathan, Tricia Y. Ting, Changxing Shao, Maureen A. Kane, Stephen W. Hoag, Xinyuan Zhang, Sam H. Haidar, Mark Flasar, Wenlei Jiang
Publikováno v:
Journal of Pharmaceutical Sciences. 105:1355-1357
We previously concluded that 12 common excipients need not be qualitatively the same and quantitatively very similar to reference for Biopharmaceutics Classification System-based biowaivers. This conclusion for regulatory relief is based upon a serie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1b9881d1067459a43f4a686be1baa0
https://doi.org/10.1016/j.xphs.2016.02.028
https://doi.org/10.1016/j.xphs.2016.02.028
Autor:
Raymond K. Cross, Mark Flasar
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 8:851-854
Unlike traditional clinical trial research, Comparative Effectiveness Research seeks to determine what is 'best' for a typical patient when deciding between effective options used in daily practice - a therapy, diagnostic test, or course of action. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944657c0989e7ad5c6d9e8d8c495703f
https://doi.org/10.1586/17474124.2014.945916
https://doi.org/10.1586/17474124.2014.945916
Publikováno v:
American Journal of Gastroenterology. 108:583-593
Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f52111790d125bd4b18baf527d4ceba
https://doi.org/10.1038/ajg.2012.464
https://doi.org/10.1038/ajg.2012.464
Publikováno v:
Inflammatory bowel diseases. 22(5)
Background Immunomodulator and biological use in African Americans (AA) with Crohn's disease (CD) has been reported to be lower than in whites (W); less data exist for Hispanics (H). Methods Medicaid databases from 3 states were examined for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eeed989deeb5acc9361d390fc1630de
https://pubmed.ncbi.nlm.nih.gov/26914436
https://pubmed.ncbi.nlm.nih.gov/26914436
Publikováno v:
Inflammatory Bowel Diseases. 16:1187-1194
Background: Outcomes of medical treatment in patients with stricturing and penetrating Crohn's disease (CD) are not well characterized. Methods: Adults with stricturing and penetrating CD who underwent medical treatment from 2004 to 2008 were evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167898e6723f78270df88e8c154983b0
https://doi.org/10.1002/ibd.21160
https://doi.org/10.1002/ibd.21160
Publikováno v:
Artificial Organs. 34:570-579
The purpose of this study was to characterize changes in hepatic venous pressures in patients with chronic hepatitis C. The histology and laboratory data from patients with chronic hepatitis C who underwent a transjugular liver biopsy (TJLB) and hepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e7ec032adbdd6f24c032839abec00f1
https://doi.org/10.1111/j.1525-1594.2009.00925.x
https://doi.org/10.1111/j.1525-1594.2009.00925.x